A detailed history of Vanguard Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,713,993 shares of BHC stock, worth $79.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,713,993
Previous 11,599,131 0.99%
Holding current value
$79.7 Million
Previous $93 Million 33.6%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$7.77 - $10.61 $892,477 - $1.22 Million
114,862 Added 0.99%
11,713,993 $124 Million
Q4 2023

Feb 14, 2024

BUY
$6.53 - $8.23 $727,200 - $916,517
111,363 Added 0.97%
11,599,131 $93 Million
Q3 2023

Nov 14, 2023

BUY
$7.69 - $9.71 $1.35 Million - $1.7 Million
175,489 Added 1.55%
11,487,768 $94.4 Million
Q2 2023

Aug 14, 2023

BUY
$5.72 - $8.8 $1.06 Million - $1.63 Million
185,159 Added 1.66%
11,312,279 $90.5 Million
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $200,721 - $314,825
31,962 Added 0.29%
11,127,120 $90.1 Million
Q4 2022

Feb 10, 2023

BUY
$6.09 - $7.93 $1.04 Million - $1.35 Million
170,783 Added 1.56%
11,095,158 $69.7 Million
Q3 2022

Nov 14, 2022

BUY
$4.58 - $9.21 $1 Million - $2.02 Million
219,279 Added 2.05%
10,924,375 $75.3 Million
Q2 2022

Aug 12, 2022

BUY
$7.06 - $23.63 $3.39 Million - $11.3 Million
479,538 Added 4.69%
10,705,096 $89.5 Million
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $7.24 Million - $9.31 Million
335,045 Added 3.39%
10,225,558 $234 Million
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $6.38 Million - $8.04 Million
277,188 Added 2.88%
9,890,513 $273 Million
Q3 2021

Nov 12, 2021

BUY
$25.04 - $30.06 $7.66 Million - $9.2 Million
306,091 Added 3.29%
9,613,325 $268 Million
Q2 2021

Aug 13, 2021

BUY
$27.43 - $32.7 $255 Million - $304 Million
9,307,234 New
9,307,234 $273 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.46B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.